Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $432.10 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $87.19 | 2 | $0 (2024) |
| Alkermes, Inc. | $83.26 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $73.23 | 4 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $52.99 | 2 | $0 (2023) |
| ABBVIE INC. | $48.59 | 2 | $0 (2024) |
| Corium, LLC | $39.96 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $23.49 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $23.39 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.00 | 4 | ABBVIE INC. ($23.53) |
| 2023 | $368.10 | 15 | Alkermes, Inc. ($83.26) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Neuroscience | ||||||
| 05/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: PSYCHOLOGY | ||||||
| 07/19/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Neuropsychiatry | ||||||
| 07/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: CNS | ||||||
| 06/13/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Neurology | ||||||
| 05/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: CNS | ||||||
| 05/08/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Central Nervous System | ||||||
| 04/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: CNS | ||||||
| 04/10/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Central Nervous System | ||||||
| 03/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $68.06 | General |
| Category: Neuroscience | ||||||
| 03/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: CNS | ||||||
| 02/16/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 62 | $28,210 | $4,782 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 62 | $28,210 | $4,782 | 17.0% |
About Elizabeth Harrison
Elizabeth Harrison is a Neuroscience healthcare provider based in Hillsborough, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2022. The National Provider Identifier (NPI) number assigned to this provider is 1225768484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elizabeth Harrison has received a total of $432.10 in payments from pharmaceutical and medical device companies, with $64.00 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($432.10).
As a Medicare-enrolled provider, Harrison has provided services to 20 Medicare beneficiaries, totaling 62 services with total Medicare billing of $4,782. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Neuroscience
- Other Specialties Psychiatric/Mental Health
- Location Hillsborough, NC
- Active Since 06/12/2022
- Last Updated 08/07/2024
- Taxonomy Code 163WN0800X
- Entity Type Individual
- NPI Number 1225768484
Products in Payments
- SPRAVATO (Drug) $87.19
- ARISTADA (Drug) $83.26
- INGREZZA (Drug) $52.99
- AUSTEDO (Drug) $52.12
- VRAYLAR (Drug) $48.59
- Azstarys (Drug) $39.96
- QELBREE (Drug) $23.49
- REXULTI (Drug) $23.39
- UZEDY (Drug) $21.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.